Follow
Mohamadreza Salehi
Mohamadreza Salehi
Head of research center for antibiotic stewardship & anti-microbial resistance, TUMS
Verified email at sina.tums.ac.ir
Title
Cited by
Cited by
Year
Maternal death due to COVID-19
S Hantoushzadeh, AA Shamshirsaz, A Aleyasin, MD Seferovic, SK Aski, ...
American journal of obstetrics and gynecology 223 (1), 109. e1-109. e16, 2020
6692020
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
M Edalatifard, M Akhtari, M Salehi, Z Naderi, A Jamshidi, S Mostafaei, ...
European Respiratory Journal 56 (6), 2020
4172020
Multiresolution knowledge distillation for anomaly detection
M Salehi, N Sadjadi, S Baselizadeh, MH Rohban, HR Rabiee
Proceedings of the IEEE/CVF conference on computer vision and pattern …, 2021
3462021
A randomized clinical trial of the efficacy and safety of interferon β-1a in treatment of severe COVID-19
E Davoudi-Monfared, H Rahmani, H Khalili, M Hajiabdolbaghi, M Salehi, ...
Antimicrobial agents and chemotherapy 64 (9), 10.1128/aac. 01061-20, 2020
3022020
The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus COVID‐19 …
K Ahmadikia, SJ Hashemi, S Khodavaisy, MI Getso, N Alijani, H Badali, ...
Mycoses 64 (8), 798-808, 2021
2082021
Opportunistic fungal infections in the epidemic area of COVID-19: a clinical and diagnostic perspective from Iran
M Salehi, K Ahmadikia, H Badali, S Khodavaisy
Mycopathologia 185 (4), 607-611, 2020
1722020
Mucormycosis in patients with COVID‐19: a cross‐sectional descriptive multicentre study from Iran
F Pakdel, K Ahmadikia, M Salehi, A Tabari, R Jafari, G Mehrparvar, ...
Mycoses 64 (10), 1238-1252, 2021
1572021
Oropharyngeal candidiasis in hospitalised COVID‐19 patients from Iran: Species identification and antifungal susceptibility pattern
M Salehi, K Ahmadikia, S Mahmoudi, S Kalantari, ...
Mycoses 63 (8), 771-778, 2020
1512020
Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial
S JamaliMoghadamSiahkali, B Zarezade, S Koolaji, SA SeyedAlinaghi, ...
European journal of medical research 26, 1-9, 2021
1502021
The novel coronavirus SARS-CoV-2 vulnerability association with ABO/Rh blood types
A Abdollahi, M Mahmoudi-Aliabadi, V Mehrtash, B Jafarzadeh, M Salehi
Iranian journal of pathology 15 (3), 156, 2020
1162020
Safety and effectiveness of azithromycin in patients with COVID-19: an open-label randomised trial
E Sekhavati, F Jafari, SA SeyedAlinaghi, S Jamalimoghadamsiahkali, ...
International journal of antimicrobial agents 56 (4), 106143, 2020
1152020
Antifungal susceptibility, genotyping, resistance mechanism, and clinical profile of Candida tropicalis blood isolates
A Arastehfar, F Daneshnia, A Hafez, S Khodavaisy, MJ Najafzadeh, ...
Medical Mycology 58 (6), 766-773, 2020
732020
Mortality predictive value of APACHE II and SOFA scores in COVID-19 patients in the intensive care unit
MT Beigmohammadi, L Amoozadeh, F Rezaei Motlagh, M Rahimi, ...
Canadian Respiratory Journal 2022, 2022
642022
Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial
E Davoudi-Monfared, H Rahmani, H Khalili, M Hajiabdolbaghi, M Salehi, ...
MedRxiv, 2020.05. 28.20116467, 2020
562020
Evaluation of molecular epidemiology, clinical characteristics, antifungal susceptibility profiles, and molecular mechanisms of antifungal resistance of Iranian Candida …
A Arastehfar, F Daneshnia, MJ Najafzadeh, F Hagen, S Mahmoudi, ...
Frontiers in cellular and infection microbiology 10, 206, 2020
482020
Low level of antifungal resistance in Iranian isolates of Candida glabrata recovered from blood samples in a multicenter study from 2015 to 2018 and potential prognostic values …
A Arastehfar, F Daneshnia, K Zomorodian, MJ Najafzadeh, S Khodavaisy, ...
Antimicrobial agents and chemotherapy 63 (7), 10.1128/aac. 02503-18, 2019
482019
Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial
R Malekzadeh, A Abedini, B Mohsenpour, E Sharifipour, R Ghasemian, ...
International Immunopharmacology 89, 107102, 2020
422020
Clinical characteristics and outcomes of 905 COVID-19 patients admitted to Imam Khomeini hospital complex in the capital city of Tehran, Iran
SF Allameh, S Nemati, R Ghalehtaki, E Mohammadnejad, SM Aghili, ...
Archives of Iranian medicine 23 (11), 766-775, 2020
412020
Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict …
A Arastehfar, F Daneshnia, M Salehi, M Yaşar, T Hoşbul, M Ilkit, W Pan, ...
Mycoses 63 (9), 911-920, 2020
402020
Paraphrase generation by learning how to edit from samples
A Kazemnejad, M Salehi, MS Baghshah
proceedings of the 58th Annual Meeting of the Association for Computational …, 2020
392020
The system can't perform the operation now. Try again later.
Articles 1–20